Skip to main content
The Journal of Cell Biology logoLink to The Journal of Cell Biology
. 1986 Jan 1;102(1):145–150. doi: 10.1083/jcb.102.1.145

Cyclosporine A, an in vitro calmodulin antagonist, induces nuclear lobulations in human T cell lymphocytes and monocytes

PMCID: PMC2114042  PMID: 3484481

Abstract

Cyclosporine A is a noncytotoxic, natural, 11 amino acid cyclic peptide used clinically as an immunosuppressant to prevent organ rejection after transplantation. Cyclosporine A is an in vitro calmodulin antagonist. At the low concentrations required to inhibit calmodulin- dependent phosphodiesterase in vitro, cyclosporine A causes a dramatic alteration in the nuclear morphology of 23% of human peripheral blood mononuclear leukocytes in vitro without loss of viability. The shape of the nucleus changes from ovoid to a distinctive, radially splayed lobulated structure. The changes occur in a dose-dependent manner in 60 min at 37 degrees C. Specific monoclonal antibodies to human leukocytes identify the cells susceptible to nuclear lobulation by cyclosporine A as OKT4 antigen-positive T cell lymphocytes and monocytes. The lobulated nuclei are 2N as determined by flow cytometric measurement of ethidium bromide fluorescence of DNA. The cyclosporine A-induced lobulation of T cell nuclei requires both physiologic temperature and metabolic energy. Although structurally different than cyclosporine A, the calmodulin antagonists R24571 and W-7 [N-(6-aminohexyl)-5-chloro-1- naphthalene-sulfonamide] also produce T cell nuclear lobulations that are indistinguishable from the nuclear lobulations caused by cyclosporine A. These data indicate that nonmitotic structural elements that govern normal nuclear morphology in a subset of mononuclear leukocytes appear to require a calmodulin-mediated process. Cyclosporine A may be a useful noncytotoxic inhibitor of calmodulin- dependent systems that influence nuclear structure and function.

Full Text

The Full Text of this article is available as a PDF (578.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borel J. F. Cyclosporin-A--present experimental status. Transplant Proc. 1981 Mar;13(1 Pt 1):344–348. [PubMed] [Google Scholar]
  2. Colombani P. M., Robb A., Hess A. D. Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes. Science. 1985 Apr 19;228(4697):337–339. doi: 10.1126/science.3885394. [DOI] [PubMed] [Google Scholar]
  3. Deery W. J., Means A. R., Brinkley B. R. Calmodulin-microtubule association in cultured mammalian cells. J Cell Biol. 1984 Mar;98(3):904–910. doi: 10.1083/jcb.98.3.904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Diamond D. A., Berry S. J., Umbricht C., Jewett H. J., Coffey D. S. Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer. Prostate. 1982;3(4):321–332. doi: 10.1002/pros.2990030402. [DOI] [PubMed] [Google Scholar]
  5. Elliott J. F., Lin Y., Mizel S. B., Bleackley R. C., Harnish D. G., Paetkau V. Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science. 1984 Dec 21;226(4681):1439–1441. doi: 10.1126/science.6334364. [DOI] [PubMed] [Google Scholar]
  6. Handschumacher R. E., Harding M. W., Rice J., Drugge R. J., Speicher D. W. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science. 1984 Nov 2;226(4674):544–547. doi: 10.1126/science.6238408. [DOI] [PubMed] [Google Scholar]
  7. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  8. Martin S. E., Zhang H. Z., Magyarosy E., Jaffe E. S., Hsu S. M., Chu E. W. Immunologic methods in cytology: definitive diagnosis of non-Hodgkin's lymphomas using immunologic markers for T- and B-cells. Am J Clin Pathol. 1984 Dec;82(6):666–673. doi: 10.1093/ajcp/82.6.666. [DOI] [PubMed] [Google Scholar]
  9. Osborn M., Weber K. Damage of cellular functions by trifluoperazine, a calmodulin-specific drug. Exp Cell Res. 1980 Dec;130(2):484–488. doi: 10.1016/0014-4827(80)90033-6. [DOI] [PubMed] [Google Scholar]
  10. Ryffel B., Götz U., Heuberger B. Cyclosporin receptors on human lymphocytes. J Immunol. 1982 Nov;129(5):1978–1982. [PubMed] [Google Scholar]
  11. Simmen R. C., Dunbar B. S., Guerriero V., Chafouleas J. G., Clark J. H., Means A. R. Estrogen stimulates the transient association of calmodulin and myosin light chain kinase with the chicken liver nuclear matrix. J Cell Biol. 1984 Aug;99(2):588–593. doi: 10.1083/jcb.99.2.588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Vindelov L. L. Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and straining of nuclei. Virchows Arch B Cell Pathol. 1977 Aug 10;24(3):227–242. [PubMed] [Google Scholar]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press

RESOURCES